Arcutis Biotherapeutics, Inc.

ARQT

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001628280-26-014642
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026
Reporting Owners: Leonard Keith R (Director)

Summary

Type

Sell

Net shares

-39,272

% of shares

-62.19%

Amount (USD)

$997,194

Insider confidence score

10.0 out of 100

Positive

  • Under Rule 10b5-1 trading plan

Negative

  • Extreme scheduled sell (≥25% of shares)
  • Large sell amount ($250K+)

Stock transactions

Transaction 1

Security

Common Stock

Action

Exercise

Date

2026-03-02

Code

M

Net shares

+27,052.0

Price per Share

$8.63

Amount (USD)

$233,458.76

Acquired/Disposed

Acquired

Shares Owned Before

22,123.0

Shares Owned After

49,175.0

Transaction 2

Security

Common Stock

Action

Exercise

Date

2026-03-02

Code

M

Net shares

+12,220.0

Price per Share

$7.51

Amount (USD)

$91,772.20

Acquired/Disposed

Acquired

Shares Owned Before

49,175.0

Shares Owned After

61,395.0

Transaction 3

Security

Common Stock

Action

Sell

Date

2026-03-02

Code

S

Net shares

-39,272.0

Price per Share

$25.39

Amount (USD)

$997,194.62

Acquired/Disposed

Disposed

Shares Owned Before

61,395.0

Shares Owned After

22,123.0

Derivative Transactions

Transaction 1

Security

Stock Option (right to buy)

Action

Exercise

Date

2026-03-02

Code

M

Net shares

-27,052.0

Acquired/Disposed

Disposed

Shares Owned Before

27,052.0

Shares Owned After

0.0

Transaction 2

Security

Stock Option (right to buy)

Action

Exercise

Date

2026-03-02

Code

M

Net shares

-12,220.0

Acquired/Disposed

Disposed

Shares Owned Before

12,220.0

Shares Owned After

0.0

Filing's footnotes

1. The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on November 18, 2025, by the Reporting Person, with a plan end date of February 16, 2027.

2. The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $25.05 to $26.039, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

3. Shares held by Leonard Family Trust dated August 28, 1996, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.

4. The option is fully vested.

ℹ️ Filed under Rule 10b5-1 trading plan

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.